The Zambia Medicines Regulatory Authority has directed all health facilities and Pharmaceutical outlets to immediately quarantine the stock of Ranitidine until further notice.
The directive follows a decision by the United States Food and Drug Administration and other Global regulators to withdraw some Ranitidine Hydrochloride tablets including branded and generic formulations due to presence of nitrosamine impurity.
In a statement issued to Money FM, Authority Director General Bernice Mwale says patients taking ranitidine are advised to stop taking the medicine and visit their physician or pharmacist for further guidance.
Mrs. Mwale adds that Physicians and Pharmacists should offer alternative medicines for their patients.
Ranitidine Hydrochloride Tablet is an oral product indicated for the relief of heartburn associated with hyperacidity and indigestion of various causes.
It is also indicated for the treatment of duodenal ulcer, benign gastric ulcer, post-operative peptic ulcer, and other conditions where reduction of gastric secretion is desirable.
Categories:
Health